Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G D Prell

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated miceG D Prell, J K Khandelwal, R S Burns, et al.
Clinical Neuropharmacology|August 1, 1996
An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacyR B Rosse, K Kendrick, M Fay-McCarthy, et al.
Schizophrenia Research|January 1, 1995
Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptomsG D Prell, J P Green, C A Kaufmann, et al.
Clinical Neuropharmacology|October 1, 1996
pros-Methylimidazoleacetic acid in cerebrospinal fluid of patients with chronic schizophrenia: relationships to ratings of symptoms, ventricular brain ratios, and rates of urine excretionG D Prell, J P Green, J K Khandelwal, et al.
Schizophrenia Research|May 1, 1996
The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patientsG D Prell, J P Green, A M Elkashef, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1991
Levels of pros-methylimidazoleacetic acid: correlation with severity of Parkinson's disease in CSF of patients and with the depletion of striatal dopamine and its metabolites in MPTP-treated miceG D Prell, J K Khandelwal, R S Burns, et al.
Clinical Neuropharmacology|August 1, 1996
An open-label study of the therapeutic efficacy of high-dose famotidine adjuvant pharmacotherapy in schizophrenia: preliminary evidence for treatment efficacyR B Rosse, K Kendrick, M Fay-McCarthy, et al.
Schizophrenia Research|January 1, 1995
Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptomsG D Prell, J P Green, C A Kaufmann, et al.
Clinical Neuropharmacology|October 1, 1996
pros-Methylimidazoleacetic acid in cerebrospinal fluid of patients with chronic schizophrenia: relationships to ratings of symptoms, ventricular brain ratios, and rates of urine excretionG D Prell, J P Green, J K Khandelwal, et al.
Schizophrenia Research|May 1, 1996
The relationship between urine excretion and biogenic amines and their metabolites in cerebrospinal fluid of schizophrenic patientsG D Prell, J P Green, A M Elkashef, et al.
Pageof 4